Literature DB >> 17158594

Congenital disorder of glycosylation type Ia presenting with hydrops fetalis.

J M van de Kamp, D J Lefeber, G J G Ruijter, S J Steggerda, N S den Hollander, S M Willems, G Matthijs, B J H M Poorthuis, R A Wevers.   

Abstract

There is a growing awareness that inborn errors of metabolism can be a cause of non-immune hydrops fetalis. The association between congenital disorders of glycosylation (CDG) and hydrops fetalis has been based on one case report concerning two sibs with hydrops fetalis and CDG-Ik. Since then two patients with hydrops-like features and CDG-Ia have been reported. Two more unrelated patients with CDG-Ia who presented with hydrops fetalis are reported here, providing definite evidence that non-immune hydrops fetalis can be caused by CDG-Ia. The presence of congenital thrombocytopenia and high ferritin levels in both patients was remarkable. These might be common features in this severe form of CDG. Both patients had one severe mutation in the phosphomannomutase 2 gene, probably fully inactivating the enzyme, and one milder mutation with residual activity, as had the patients reported in literature. The presence of one severe mutation might be required for the development of hydrops fetalis. CDG-Ia should be considered in the differential diagnosis of hydrops fetalis and analysis of PMM activity in chorionic villi or amniocytes should also be considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158594      PMCID: PMC2598051          DOI: 10.1136/jmg.2006.044735

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  30 in total

1.  Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia.

Authors:  P Briones; M A Vilaseca; E Schollen; I Ferrer; M Maties; C Busquets; R Artuch; L Gort; M Marco; E van Schaftingen; G Matthijs; J Jaeken; A Chabás
Journal:  J Inherit Metab Dis       Date:  2002-12       Impact factor: 4.982

2.  Failure to diagnose carbohydrate-deficient glycoprotein syndrome prenatally.

Authors:  H Stibler; F Skovby
Journal:  Pediatr Neurol       Date:  1994-07       Impact factor: 3.372

3.  Prenatal hypertrophic cardiomyopathy and pericardial effusion in carbohydrate-deficient glycoprotein syndrome.

Authors:  M T García Silva; J de Castro; H Stibler; R Simón; A Chasco Yrigoyen; F Mateos; I Ferrer; S Madero; J M Velasco; F Guttierrez-Larraya
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

4.  Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.

Authors:  A Erlandson; C Bjursell; H Stibler; B Kristiansson; J Wahlström; T Martinsson
Journal:  Hum Genet       Date:  2001-05       Impact factor: 4.132

Review 5.  The carbohydrate-deficient glycoprotein syndromes: an overview.

Authors:  J Jaeken; H Carchon
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).

Authors:  G Matthijs; E Schollen; C Bjursell; A Erlandson; H Freeze; F Imtiaz; S Kjaergaard; T Martinsson; M Schwartz; N Seta; S Vuillaumier-Barrot; V Westphal; B Winchester
Journal:  Hum Mutat       Date:  2000-11       Impact factor: 4.878

7.  A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases.

Authors:  P de Lonlay; N Seta; S Barrot; B Chabrol; V Drouin; B M Gabriel; H Journel; M Kretz; J Laurent; M Le Merrer; A Leroy; D Pedespan; P Sarda; N Villeneuve; J Schmitz; E van Schaftingen; G Matthijs; J Jaeken; C Korner; A Munnich; J M Saudubray; V Cormier-Daire
Journal:  J Med Genet       Date:  2001-01       Impact factor: 6.318

8.  Severe transient myocardial ischaemia caused by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia.

Authors:  Thorsten Marquardt; Georg Hülskamp; Josef Gehrmann; Volker Debus; Erik Harms; Hans Gerd Kehl
Journal:  Eur J Pediatr       Date:  2002-08-22       Impact factor: 3.183

9.  Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype.

Authors:  S Kjaergaard; M Schwartz; F Skovby
Journal:  Arch Dis Child       Date:  2001-09       Impact factor: 3.791

10.  Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coli.

Authors:  S Kjaergaard; F Skovby; M Schwartz
Journal:  Eur J Hum Genet       Date:  1999-12       Impact factor: 4.246

View more
  22 in total

1.  Congenital Disorder of Glycosylation (CDG) Presenting as Non-immune Hydrops Fetalis.

Authors:  Nalinikanta Panigrahy; Lokesh Lingappa; Akela Radha Ramadevi; Alla Venkatlakshmi
Journal:  Indian J Pediatr       Date:  2015-09-14       Impact factor: 1.967

2.  TMEM165 Deficiency: Postnatal Changes in Glycosylation.

Authors:  S Schulte Althoff; M Grüneberg; J Reunert; J H Park; S Rust; C Mühlhausen; Y Wada; R Santer; T Marquardt
Journal:  JIMD Rep       Date:  2015-08-04

Review 3.  Recognizable phenotypes in CDG.

Authors:  Carlos R Ferreira; Ruqaia Altassan; Dorinda Marques-Da-Silva; Rita Francisco; Jaak Jaeken; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2018-04-13       Impact factor: 4.982

4.  Mild clinical and biochemical phenotype in two patients with PMM2-CDG (congenital disorder of glycosylation Ia).

Authors:  M Casado; M M O'Callaghan; R Montero; C Pérez-Cerda; B Pérez; P Briones; E Quintana; J Muchart; A Aracil; M Pineda; R Artuch
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

5.  PMM2-CDG and sensorineural hearing loss.

Authors:  Çiğdem Seher Kasapkara; Zeren Barış; Mustafa Kılıç; Deniz Yüksel; Lies Keldermans; Gert Matthijs; Jaak Jaeken
Journal:  J Inherit Metab Dis       Date:  2017-07-31       Impact factor: 4.982

Review 6.  Cardiac complications of congenital disorders of glycosylation (CDG): a systematic review of the literature.

Authors:  D Marques-da-Silva; R Francisco; D Webster; V Dos Reis Ferreira; J Jaeken; T Pulinilkunnil
Journal:  J Inherit Metab Dis       Date:  2017-07-19       Impact factor: 4.982

7.  Comprehensive description of the phenotype of the first case of congenital disorder of glycosylation due to RFT1 deficiency (CDG In).

Authors:  P T Clayton; S Grunewald
Journal:  J Inherit Metab Dis       Date:  2009-03-11       Impact factor: 4.982

8.  Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening.

Authors:  S Vermeer; H P H Kremer; Q H Leijten; H Scheffer; G Matthijs; R A Wevers; N A V M Knoers; E Morava; D J Lefeber
Journal:  J Neurol       Date:  2007-08-15       Impact factor: 4.849

9.  Further Delineation of the ALG9-CDG Phenotype.

Authors:  Sarah AlSubhi; Amal AlHashem; Anas AlAzami; Kalthoum Tlili; Saad AlShahwan; Dirk Lefeber; Fowzan S Alkuraya; Brahim Tabarki
Journal:  JIMD Rep       Date:  2015-10-10

10.  Lysosomal storage disease spectrum in nonimmune hydrops fetalis: a retrospective case control study.

Authors:  Huda B Al-Kouatly; Laura Felder; Mona M Makhamreh; Stephanie L Kass; Neeta L Vora; Vincenzo Berghella; Seth Berger; David A Wenger; Paola Luzi
Journal:  Prenat Diagn       Date:  2020-03-20       Impact factor: 3.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.